Literature DB >> 10213101

Optimum duration of splinting after endopyelotomy.

R Kumar1, R Kapoor, A Mandhani, A Kumar, R Ahlawat.   

Abstract

OBJECTIVE: Endopyelotomy is a well-accepted modality of treatment for pelviureteral junction (PUJ) obstruction, but the time period of stenting is debatable. The present study was aimed at evaluating the optimum duration and effectiveness of splinting after endopyelotomy. PATIENTS AND METHODS: Twenty-nine consecutive patients with primary PUJ obstruction were randomized to have an external splint (for economic reasons) for 2 weeks or 4 weeks. Thirteen patients in each group were available for evaluation. The groups were comparable in age, sex, symptoms, and preoperative glomerular filtration rate (GFR). All patients underwent antegrade endopyelotomy with placement of an 8F-12F polyethylene splint across the PUJ. A nephrostogram was performed after removal of splint at 2 or 4 weeks. Nondraining units were managed by putting in a 6F double-J stent for 6 weeks and considered failures. Patients were evaluated at 3, 6, and 12 months for symptomatic improvement, change in GFR, and drainage pattern on a diuretic renogram.
RESULTS: At 1 year, a nonobstructed curve pattern was seen in 70% and improvement in GFR in 54% of the patients in the 2-weeks group, whereas in the 4-weeks group, these values were 54% and 39%, respectively. All patients in the 4-weeks group and 90% of those in the 2-weeks group were symptom free at 1 year of follow-up. Morbidity in terms of tube-related complications was comparable.
CONCLUSION: Two weeks of splinting is as effective as 4 weeks in the successful outcome of endopyelotomy.

Entities:  

Mesh:

Year:  1999        PMID: 10213101     DOI: 10.1089/end.1999.13.89

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  3 in total

1.  Endopyelotomy - a Minimally Invasive Surgical Option for Pelvi-ureteric Junction Obstruction: a Study Of 34 Cases.

Authors:  A A Pradhan; Rajeev Sood; P Madhusoodanan; A S Sandhu; S K Gupta; Anil Kumar
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  The role of percutaneous endopyelotomy for ureteropelvic junction obstruction.

Authors:  N J Rukin; D A Ashdown; P Patel; S Liu
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

Review 3.  The role of endourology in ureteropelvic junction obstruction.

Authors:  P J Van Cangh; S Nesa; B Tombal
Journal:  Curr Urol Rep       Date:  2001-04       Impact factor: 2.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.